Your browser doesn't support javascript.
loading
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.
Visconti, Alessia; Rossi, Niccolò; Deris, Helena; Lee, Karla A; Hanic, Maja; Trbojevic-Akmacic, Irena; Thomas, Andrew M; Bolte, Laura A; Björk, Johannes R; Hooiveld-Noeken, Jahlisa S; Board, Ruth; Harland, Mark; Newton-Bishop, Julia; Harries, Mark; Sacco, Joseph J; Lorigan, Paul; Shaw, Heather M; de Vries, Elisabeth G E; Fehrmann, Rudolf S N; Weersma, Rinse K; Spector, Tim D; Nathan, Paul; Hospers, Geke A P; Sasieni, Peter; Bataille, Veronique; Lauc, Gordan; Falchi, Mario.
Afiliación
  • Visconti A; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK.
  • Rossi N; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK.
  • Deris H; Genos Glycoscience Research Laboratory, Zagreb, Croatia.
  • Lee KA; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK.
  • Hanic M; Genos Glycoscience Research Laboratory, Zagreb, Croatia.
  • Trbojevic-Akmacic I; Genos Glycoscience Research Laboratory, Zagreb, Croatia.
  • Thomas AM; CIBIO, University of Trento, Trento, Italy.
  • Bolte LA; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands.
  • Björk JR; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands.
  • Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Board R; Department of Oncology, Lancashire Teaching Hospitals NHS Trust, Chorley, UK.
  • Harland M; Division of Haematology and Immunology, Institute of Medical Research at St. James', University of Leeds, Leeds, UK.
  • Newton-Bishop J; Division of Haematology and Immunology, Institute of Medical Research at St. James', University of Leeds, Leeds, UK.
  • Harries M; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sacco JJ; Liverpool Clatterbridge Cancer Centre, Liverpool, UK.
  • Lorigan P; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Shaw HM; The Christie NHS Foundation Trust, Manchester, UK.
  • de Vries EGE; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
  • Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Weersma RK; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Spector TD; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center, Groningen, The Netherlands.
  • Nathan P; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK.
  • Hospers GAP; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
  • Sasieni P; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Bataille V; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Lauc G; Department of Twins Research & Genetics Epidemiology, King's College London, London, UK. bataille@doctors.org.uk.
  • Falchi M; Department of Dermatology, Mount Vernon Cancer Centre, Northwood, UK. bataille@doctors.org.uk.
BMC Cancer ; 23(1): 166, 2023 Feb 18.
Article en En | MEDLINE | ID: mdl-36805683
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido